Author Correction: Prevalence of smoldering multiple myeloma based on nationwide screening
Nat Med
.
2023 Dec;29(12):3269.
doi: 10.1038/s41591-023-02308-5.
Authors
Sigrún Thorsteinsdóttir
1
2
,
Gauti K Gíslason
1
,
Thor Aspelund
3
,
Sæmundur Rögnvaldsson
1
,
Jón Þórir Óskarsson
1
,
Guðrún Á Sigurðardóttir
1
,
Ásdís R Þórðardóttir
1
,
Brynjar Viðarsson
4
,
Páll T Önundarson
4
,
Bjarni A Agnarsson
4
,
Margrét Sigurðardóttir
4
,
Ingunn Þorsteinsdóttir
4
,
Ísleifur Ólafsson
4
,
Elías Eyþórsson
4
,
Ásbjörn Jónsson
4
,
Oscar Berlanga
5
,
Malin Hultcrantz
6
,
Brian G M Durie
7
,
Thorvardur J Löve
1
,
Stephen Harding
5
,
Ola Landgren
8
,
Sigurður Y Kristinsson
9
10
Affiliations
1
Faculty of Medicine, University of Iceland, Reykjavík, Iceland.
2
Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
3
Public Health Sciences, University of Iceland, Reykjavík, Iceland.
4
Landspítali University Hospital, Reykjavík, Iceland.
5
The Binding Site, Birmingham, UK.
6
Memorial Sloan Kettering Cancer Center, New York, NY, USA.
7
Cedars-Sinai Samual Oschin Cancer Center, Los Angeles, CA, USA.
8
Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
9
Faculty of Medicine, University of Iceland, Reykjavík, Iceland. sigyngvi@hi.is.
10
Landspítali University Hospital, Reykjavík, Iceland. sigyngvi@hi.is.
PMID:
36941333
DOI:
10.1038/s41591-023-02308-5
No abstract available
Publication types
Published Erratum
Grants and funding
716677/EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
173857/Icelandic Centre for Research (Rannsóknamiðstöð Íslands)